NCT00258271 2013-10-16Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous LeukemiaUniversity of RochesterPhase 1 Completed18 enrolled